Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-5_13-cv-02420/USCOURTS-cand-5_13-cv-02420-16/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

1 

Case Nos.: 13-CV-02420-LHK 

CASE MANAGEMENT ORDER 

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

United States District Court 

For the Northern District of California 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

SAN JOSE DIVISION 

TAKEDA PHARMACEUTICAL CO., LTD.,

TAKEDA PHARMACEUTICALS U.S.A., 

INC., AND TAKEDA 

PHARMACEUTICALS AMERICA, INC., 

 Plaintiffs, 

 

 v. 

TWI PHARMACEUTICALS, INC., 

 Defendant. 

)

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

) 

)

Case No.: 13-CV-02420-LHK 

CASE MANAGEMENT ORDER 

Plaintiffs’ Attorneys: Jeffrey Weinberger; Ted Dane; Heather Takahashi; John Schwab

Defendant’s Attorneys: Don J. Mizerk; John Sholar

A case management conference was held on April 9, 2015. 

Each side is limited to four (4) motions in limine. Each motion and opposition shall not 

exceed five (5) pages in length. The parties may not file replies. 

The parties stipulated to shorten the length of trial to five (5) days. Accordingly, the case 

schedule is as follows: 

Scheduled Event Date 

Deadline for Takeda to File and Serve a Narrowed List of 

Asserted Claims 

April 16, 2015 

(max 5 claims) 

Final Pretrial Conference May 14, 2015, at 1:30 p.m. 

Bench Trial June 2, 2015, at 9:00 a.m. 

Length of Trial 5 days 

IT IS SO ORDERED.

Dated: April 9, 2015 _________________________________ 

 LUCY H. KOH 

 United States District Judge 

Case 5:13-cv-02420-LHK Document 167 Filed 04/09/15 Page 1 of 1